2013
A stylish, in-depth look at the renaissance in psychedelic drug research in light of current scientific, medical, and cultural knowledge.
85 min
CLEAR ALL
A well-kept American secret is that the CIA-funded research that exploited incarcerated Black Americans along with other vulnerable groups in America’s hunt for a “mind-control” drug.
A new study finds widespread exclusion of minorities in psychedelic research.
1
Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.
A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).
Dr. Monnica T. Williams discusses her work in assessing racial trauma and mental health disparities in African-American communities.
In this timely webinar - moderated by Chief Psychologist (USA) Dr. Dominique Morisano - clinical psychologist and thought-leader Dr.
The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry
There is a growing research literature suggesting psychedelics hold incredible promise for treating mental health ailments ranging from depression and anxiety to PTSD. But how do we know for sure?